EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

Br J Cancer · 2013 · PMC3629430 · PMID 23519058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The luminal A and the luminal B HER2 − subtypes also showed a trend towards decreased OS with EpCAM expression ( Table 5 and Figure 2 ), but this was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.